News

A fractional resurfacing technique that uses a 1927 nm nonablative thulium laser reduces the number of facial actinic keratosis and provides noticeable clearance of photodamage, results of a recent study indicate.

Consumers who use smartphone applications to analyze suspicious lesions or moles are at risk of having inaccurate diagnoses and delayed treatments, results of a new study indicate.

Intermittent dosing of vemurafenib extended the lives of lab mice with drug-resistant melanoma tumors, according to results of an international study.

Having reached the end of a 10-month injunction barring it from selling its botulinum toxin product in the U.S., Merz is once again launching Xeomin for the treatment of glabellar lines.

Atopic dermatitis coupled with food allergy in early childhood speeds up allergic progression, according to findings from a recent study.

Patients with rheumatoid arthritis who use anti-tumor necrosis factor treatments may have an increased risk of shingles, according to researchers.

Washington - Unapproved versions of onabotulinumtoxinA (Botox, Allergan) sent by foreign suppliers has prompted the Food and Drug Administration to issue alerts to more than 350 medical practices that may have purchased the products.

New York - A newly formed group of indoor tanning retailers is working to correct what it calls “misinformation” about tanning beds and boost public awareness of the potential benefits of UV exposure.

Lausanne, Switzerland - Pharmaceutical company Galderma is poised to acquire Spirig Pharma, a move that will boost its line of products for treating various dermatologic conditions.

Winston-Salem, N.C. - Pain is a significant predictor of squamous cell carcinoma compared to basal cell carcinoma, according to results of a recent study.

Washington - The Food and Drug Administration’s final rule for sunscreen labeling requirements went into effect Dec. 17, impacting manufacturers with annual product sales of more than $25,000.

New York - Patients who have visible facial skin conditions such as acne and vitiligo can derive emotional benefits from cosmetic camouflage therapy, results of a recent study indicate.

Patients taking telaprevir for hepatitis C are at risk of developing a serious skin rash that could be fatal, the Food and Drug Administration has warned.

A recent court ruling allows pharmaceutical representatives to tell doctors about appropriate off-label uses of medications without risking a penalty from federal authorities.

Audits : The fight against fraud is heating up, and dermatologists may be at risk. Protect yourself by being proactive. FDA clears PicoSure for tattoo removal Clinical Dermatology : When tackling challenging eczema, think outside the box Special Report : Implementing small practice-related changes can make a big difference in patient perception Cutaneous Oncology : High-tech imaging helps to identify perineural spread of malignancies Cosmetic Dermatology : HA filler can address complications associated with tear trough correction Business of Dermatology : Ensure HIPAA compliance in your social media strategies

Patients find physicians more approachable when they are wearing “business casual” dress, according to the results of a patient questionnaire. Respondents still prefer the hallmark white coat, however.

Revolutionized by the advent of fractional laser technology, laser surgery for scars continues to evolve. However, clinicians continue to be confronted with a wide variety of scar types without a well-established treatment algorithm.

The first hyaluronic acid (HA) dermal filler indicated specifically for the tear troughs provides a safe, long-lasting alternative to previous HA options in this area, says Hassan Galadari, M.D.

The Food and Drug Administration has given Cynosure 510(k) clearance to market its PicoSure laser workstation for removing tattoos and pigmented lesions.

In an ethical attempt to limit the numbered of required patient visits, Dr. Smith often will treat 20 to 30 solar keratoses in one visit. Dr. Smith has taken courses on proper coding and codes in a recognized, honest and ethical manner. Unfortunately, several of his carriers inform him that only 15 actinic keratoses can be treated at each visit, and only four such visits are allowed during a year for each patient.

Dermatologists have become extremely reluctant to participate in hospital activities such as evaluating in-patients as consultants, serving on hospital committees, and participating in educational activities in the hospital. the most troubling is our resistance to see patients at the hospital bedside. There are a number of apparently legitimate excuses for the failure of dermatologists to visit the hospital wards.

The Food and Drug Administration has approved a supplemental new drug application for a topical local anesthetic cream to be used in superficial cosmetic procedures.

The iPhone is among the top devices consumers are using to gather medical information, according to a recent survey.

A mouse model indicates that a protein-rich diet high in arginine and proline may improve chronic wound healing.

Exposure to ultraviolet nail lamps does not increase the risk of developing skin cancer, a recent study indicates.

Plastic surgeons have identified molecular changes in molecules that regulate gene activity that may serve as critical makers to tissue aging, allowing for less invasive avenues to improve the skin’s appearance, according to a new study.

An online service based in western Pennsylvania aims to get more patient cases in front of dermatologists faster.

The American Academy of Dermatology has named Elaine Weiss, J.D., as its new executive director and CEO, starting Feb. 7.

Allergan has announced plans to acquire SkinMedica’s topical aesthetics skincare business for $350 million.

Dermatologist Tina Alster, M.D., has joined Dermatology Times’ Editorial Advisory Council.